NKF KDOQI GUIDELINES Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis | Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone | Anemia 2006 | Updates 2006 | Diabetes and Chronic Kidney Disease

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease

Tables
Figures
Acronyms and Abbreviations
Work Group Membership
KDOQI Advisory Board Members
Foreword
Disclaimer

1. EXECUTIVE SUMMARY
   • Executive Summary
     
2. CLINICAL PRACTICE GUIDELINES
   • Background
   • Guideline 1: Screening and Diagnosis of Diabetic Kidney Disease
   • Guideline 2: Management of Hyperglycemia and General Diabetes Care in Chronic Kidney Disease
   • Guideline 3: Management of Hypertension in Diabetes and Chronic Kidney Disease
   • Guideline 4: Management of Dyslipidemia in Diabetes and Chronic Kidney Disease
   • Guideline 5: Nutritional Management in Diabetes and Chronic Kidney Disease
     
3. CLINICAL PRACTICE RECOMMENDATIONS
   • Clinical Practice Recommendation 1: Management of Albuminuria in Normotensive Patients With Diabetes and Albuminuria as a Surrogate Marker
   • Clinical Practice Recommendation 2: Multifaceted Approach to Intervention in Diabetes and Chronic Kidney Disease
   • Clinical Practice Recommendation 3: Diabetes and Chronic Kidney Disease in Special Populations
   • Clinical Practice Recommendation 4: Behavioral Self-Management in Diabetes and Chronic Kidney Disease
     
4. RESEARCH RECOMMENDATIONS
   • Research Recommendation

APPENDICES

• Appendix 1: Nutritional Management of Diabetes and Chronic Kidney Disease
• Appendix 2: Methods for Evaluating Evidence

WORK GROUP BIOGRAPHIES, ACKNOWLEGMENTS, & REFERENCES

• Work Group Biographies
• Acknowledgments
• References
  

Back to top

© 2007 National Kidney Foundation, Inc.